Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
124.15
+1.23 (1.00%)
At close: Mar 31, 2025, 4:00 PM
124.50
+0.35 (0.28%)
Pre-market: Apr 1, 2025, 6:44 AM EDT
Jazz Pharmaceuticals (JAZZ) Revenue by Segment
History
| Date | Neuroscience | Oncology |
|---|---|---|
| Sep 30, 2024 | 2.66B | 1.09B |
| Jun 30, 2024 | 2.63B | 1.07B |
| Mar 31, 2024 | 2.64B | 1.04B |
| Dec 31, 2023 | 2.71B | 1.02B |
| Sep 30, 2023 | 2.76B | 965.36M |
| Jun 30, 2023 | 2.80B | 928.30M |
| Mar 31, 2023 | 2.80B | 905.92M |
| Dec 31, 2022 | 2.76B | 873.84M |
| Sep 30, 2022 | 2.71B | 857.05M |
| Jun 30, 2022 | 2.64B | 818.48M |
| Mar 31, 2022 | 2.52B | 752.44M |
| Dec 31, 2021 | 2.34B | 733.81M |
| Sep 30, 2021 | 2.11B | 723.21M |
| Jun 30, 2021 | 1.92B | 676.58M |
| Mar 31, 2021 | 1.80B | 650.94M |
| Dec 31, 2020 | 1.79B | 590.65M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.